Biography
Dr. Liang Xu obtained his M.D. and Ph.D. in Gastroenterology at the Fourth Military Medical University of China in 1992 and did residency there. He did post-doc research on molecular biology at University of Louvain, Belgium, 1994, then at Stanford University, 1996. He moved to the Georgetown University and developed a novel non-viral tumor-targeted delivery system for cancer therapy, which is in Phase II clinical trials. In 2002, he joined the faculty at University of Michigan to discover the novel small molecule inhibitors of anti-apoptotic proteins. He is a co-inventor of the first Bcl-2 inhibitor that entered clinical trials. In 2010, he obtained a Rising Star Scholar Award and became an Associate Professor with Tenure at University of Kansas Cancer Center. He has >25 patents with four INDs in advanced clinical trials. He is now a Professor of Cancer Biology at University of Kansas and has been funded by NIH, DOD and Komen Foundation. He is now working on cancer drug discovery and immunotherapy targeting cancer stem cells.
Research Interest
Molecular therapy targeting cancer and cancer stem cells, via novel nanovectors and rational drug design.
Novel small-molecule cancer therapeutics - Drug discovery and molecular cancer therapy.
Novel nanovector delivery systems targeting cancer and cancer stem cells - Drug/gene delivery.
Related Publications
-
Toxic Megacolon: Management Challenges
Review Article: Res Rep Gastroenterol
DOI:
Stella Compagnoni, Marta Chiavetta and Mario Cottone
-
The Relation between Helicobacter Pylori Infection, Serum Ammonia and Hepatic Encephalopathy in Yemeni Cirrhotic Patients
Research Article: Res Rep Gastroenterol
DOI:
Mansour A Al-Amrani and Ali Ahmed Al-Zaazaai
-
Global presence of your research at world gastroenterology 2020 scheduled during April 06-07, 2020 at Osaka, Japan
Commentary: Res Rep Gastroenterol
DOI:
Dr. Vinod
-
16th World Congress on Gastroenterology & Therapeutic
Commentary: Res Rep Gastroenterol
DOI:
Dr. Vinod
-
Awards 2020 on Digestive Disease
Awards 2020: Res Rep Gastroenterol
DOI:
Ahmed Hegazi
-
Digestive Disease 2020 scheduled at Venice, Italy during June 22-23, 2020
2020 Conference Announcement: Res Rep Gastroenterol
DOI:
Ahmed Hegazi
-
Markey Analysis of 6th International Conference on Public Health and Nutrition
Market Analysis: Res Rep Gastroenterol
DOI:
Mark Woodward
-
Global Conference on Gastroenterology
Market Analysis: Res Rep Gastroenterol
DOI:
Henry Buchwald
-
Global Conference on Gastroenterology
Market Analysis: Res Rep Gastroenterol
DOI:
Dana K. Andersen
-
Young Research Forum-Young Scientist Awards at Gastro 2020
Young Research Forum: Res Rep Gastroenterol
DOI:
Henadzi Filipenka
-
Announcement -Obesity & Nutrition Conference 2020
2020 Conference Announcement: Res Rep Gastroenterol
DOI:
Karantonis Charalambos
-
Market Analysis on Gastroenterology
Market Analysis: Res Rep Gastroenterol
DOI:
Dr. Vinod Nikhra
-
ANNOUNCEMENT GASTROENTEROLOGY 2020 GASTROENTEROLOGY & HEPATOLOGY 2020 SCHEDULED AT DUBAI, UAE DURING AUGUST 26-27, 2020
2020 Conference Announcement: Res Rep Gastroenterol
DOI:
prabhu
-
Awards Gastroenterology 2020 on 4th International Conference on Gastroenterology & Hepatology
Awards 2020: Res Rep Gastroenterol
DOI:
Hedii Filipenka
-
Young Researchers Forum - Young Scientist Awards Gastroenterology 2020
Young Research Forum: Res Rep Gastroenterol
DOI:
Henry Buchwald
-
Obesity 2020_Market Analysis
Market Analysis: Res Rep Gastroenterol
DOI:
Athanasaki Eirini
-
Colorectal Cancer
Editorial: Res Rep Gastroenterol
DOI:
Lee Le Ye
-
Malignant Appendeceal Carcinoid Tumour with Intestinal Obstruction and Caecal Perforation: A Case Report in Northern Ghana
Research Article: Res Rep Gastroenterol
DOI:
Der EM and Abantanga FA
-
Carcinoid Tumours in Gastroenterology
Editorial: Res Rep Gastroenterol 2020, 4:1
DOI:
Cheng Zhang
-
Awards 2020 on Digestive Disease
Awards 2020: Res Rep Gastroenterol
DOI:
Ahmed Hegazi
-
Digestive Disease
2020 Conference Announcement: Res Rep Gastroenterol
DOI:
Ahmed Hegazi
-
4th International Conference on Digestive Diseases 2020 Market Analysis
Market Analysis: Res Rep Gastroenterol
DOI:
Ahmed Hegazi
-
Young Scientist Awards at Digestive and Metabolic Diseases for the best researches in Digestive Disease
Young Research Forum: Res Rep Gastroenterol
DOI:
Ahmed Hegazi
-
The Study of Intestinal Permeability and its Relationship with Autism
Editorial: Res Rep Gastroenterol 2017, 1:1
DOI:
Menicagli R and Marotta O
-
Gastric Schwannoma: A Rare Case with Preoperative Diagnosis by EUS-FNB
Clinical Image: Res Rep Gastroenterol 2018, 2:1
DOI:
Khamaysi I and Malkin L
-
Inverted Meckels Diverticulum as the cause of Intussusception in Adults
Case Report: Res Rep Gastroenterol 2017, 1:1
DOI:
Shenouda M, Reid J, DeRogatis MJ, Gaspard S and Hinika G
-
Primary Acquired Gastric Outlet Obstruction in Pediatrics (Jodhpur Disease) How to Manage? A Report of Two Cases
Case Report: Res Rep Gastroenterol 2018, 2:1
DOI:
Takrouney MH, Sabra TA, Ibrahim H and Ahmed MEL
-
Successful Biliary Navigation Using Air in Malignant and Post-Surgical Hilar Strictures: A Prospective Controlled Trial
Research Article: Res Rep Gastroenterol 2018, 2:1
DOI:
Elshimi E, Attia AE, Eljaky A, Elshazly H and Allam M
-
Hepatitis C Infection and Paroxysmal Nocturnal Hemoglobinuria with Complicated Course: Coincidental Association or True Link?
Case Report: Res Rep Gastroenterol 2017, 1:1
DOI:
Chakkor A, Arar A,Sanciu R,Legac E,Cacoub P and Ahmed SNS
-
An Unusual Case of Dyspnoea in a Patient with Chronic Liver Disease
Case Report: Res Rep Gastroenterol 2018, 2:1
DOI:
Johnson A, Mitchell D, Batchelor S, Kaura S and Islam M
-
Rectal Melanoma with Duodenal Metastasis: Very Unusual Endoscopic Findings
Case Report: Res Rep Gastroenterol 2017, 1:1
DOI:
Feldman D, Mari A, Abu-Backer F and Kopelman Y
-
Crohns Colitis with Marked Peripheral Eosinophilia
Case Report: Res Rep Gastroenterol 2017, 1:1
DOI:
Matar K, Helal A, Yaacoub A and Mari A
-
Perforated Sigmoid Volvulus in an Elderly Male with Expressive Aphasia
Case Report: Res Rep Gastroenterol 2018, 2:1
DOI:
Steven KM Vuu, Tania Zavalza Jimenez, Carlos E Ramirez, Michael J DeRogatis* and Gudata Hinika
